01
The Genelyra Infrastructure
Genelyra unites blockchain technology with life science data infrastructure — a secure new digital foundation for genetic research, innovative drug development, personalized medicine and frontier life science.
02
A Connected Ecosystem
One verifiable data layer connects research institutions, biotech enterprises, developers and ecosystem participants, enabling collaboration that is safer, more transparent and more efficient.
03
Powering Life Science
The network powers genetic research, innovative drug R&D, personalized medicine and frontier life science programs with shared, traceable data.
04
Subscription Terms
Each GELY is offered at 1.8 USDT, with a minimum subscription of 500 GELY and a maximum of 1,000,000 GELY per participant.
05
From Allocation to Listing
Participants who complete the subscription enter the token allocation phase. GELY lists on October 12, 2026, alongside the launch of the Early Fan Program.